In July ----, the Minister of Health and Social Development of Kazakhstan (MZSR) announced that the country will implement a reference pricing mechanism in order to regulate medicine pricing. Also in July ----, the MZSR announced the rollout of a trial for a simplified procedure for prescribing state guaranteed free medicines in Astana, which is hoped to be implemented throughout all regions of Kazakhstan by ---- if proven successful. ...In July ----, the Minister of Health and Social Development of Kazakhstan (MZSR) announced that the country will implement a reference pricing mechanism in order to regulate medicine pricing. Also in July ----, the MZSR announced the rollout of a trial for a simplified procedure for prescribing state guaranteed free medicines in Astana, which is hoped to be implemented throughout all regions of Kazakhstan by ---- if proven successful. In June ----, the MZSR held a seminar promoting the use of generic medicines which was attended by a number of pharmacists, doctors and healthcare workers. ...In June ----, the MZSR held a seminar promoting the use of generic medicines which was attended by a number of pharmacists, doctors and healthcare workers. In May ----, Kazakh MPs approved an agreement with Armenia allowing their pharmaceutical manufacturers to import medicine to Kazakhstan on facilitated conditions.
...BMI View: Kazakhstan s pharmaceutical market has grown significantly in the past five years thanks to impressive developments in the public healthcare system. However, in order for the government to achieve its goals on life expectancy and other key areas, the healthcare sector will need to receive increased and effective investments over the long term. ...BMI View: Kazakhstan s pharmaceutical market has grown significantly in the past five years thanks to impressive developments in the public healthcare system. However, in order for the government to achieve its goals on life expectancy and other key areas, the healthcare sector will need to receive increased and effective investments over the long term. Limited state coverage of medicines and lack of doctors currently inhibit the market. ...Limited state coverage of medicines and lack of doctors currently inhibit the market. As coverage to patients improves in the coming years, spurred on by the eventual introduction of a mandatory health insurance scheme in ----, we expect the overall market to be driven mainly by generic drug sales, although we expect patented medicines to perform well as well.
...BMI View: The implementation of a new health insurance scheme, as well as policies to stabilise medicine prices and increase accessibility of drugs, will boost pharmaceutical sales in Kazakhstan. Furthermore, the stabilisation of the tenge and improved outlook of the Kazakh economy will bolster foreign import sales. ...
